Articles with public access mandates - Jelle WesselingLearn more
Not available anywhere: 9
Review
Tumour-specific proline vulnerability uncovered by differential ribosome codon reading
F Loayza-Puch, K Rooijers, LCM Buil, J Zijlstra, J F. Oude Vrielink, ...
Nature 530 (7591), 490-494, 2016
Mandates: Netherlands Organisation for Scientific Research, European Commission, Dutch …
Review
Response to preoperative radiation therapy in relation to gene expression patterns in breast cancer patients
SCJ Bosma, M Hoogstraat, F van der Leij, M de Maaker, J Wesseling, ...
International Journal of Radiation Oncology* Biology* Physics 106 (1), 174-181, 2020
Mandates: Dutch Cancer Society
Review
Archival single-cell genomics reveals persistent subclones during DCIS progression
K Wang, T Kumar, J Wang, DC Minussi, E Sei, J Li, TM Tran, ...
Cell 186 (18), 3968-3982. e15, 2023
Mandates: US Department of Defense, US National Institutes of Health, Cancer Research …
Review
Breast-conserving therapy in patients with cT3 breast cancer with good response to neoadjuvant systemic therapy results in excellent local control: a comprehensive cancer …
MEM van der Noordaa, I Ioan, EJ Rutgers, E van Werkhoven, CE Loo, ...
Annals of surgical oncology 28 (12), 7383-7394, 2021
Mandates: Cancer Research UK, Dutch Cancer Society
Review
Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment
S Delaloge, SA Khan, J Wesseling, T Whelan
The Lancet, 2024
Mandates: Cancer Research UK, Netherlands Organisation for Health Research and Development
Review
The successful patient-preference design for the LORD-trial to test whether active surveillance for low-risk Ductal Carcinoma In Situ is safe
R Schmitz, C Sondermeijer, V Van der Noort, E Engelhardt, M Gerritsma, ...
European Journal of Cancer 175, S3-S4, 2022
Mandates: Cancer Research UK, Dutch Cancer Society
Review
Mammary duct detection using self-supervised encoders
S Doyle, F Dal Canton, J Wesseling, CI Sánchez, J Teuwen
Medical Imaging 2022: Computer-Aided Diagnosis 12033, 229-232, 2022
Mandates: Cancer Research UK, Dutch Cancer Society
Review
FaMRIsc trial shows: MRI breast screening for women with≥ 20% lifetime risk is also cost-effective in Europe
M Tilanus-Linthorst, A Geuzinge, IM Obdeijn, E Rutgers, R Mann, ...
European Journal of Surgical Oncology 47 (2), e19, 2021
Mandates: Netherlands Organisation for Health Research and Development, Dutch Cancer …
Review
THU0471 Identifying Trajectories in Knee Osteophyte Formation in Early Osteoarthritis; Results of 5 Year Follow-Up in Check (Cohort HIP and Cohort Knee)
J Wesseling, N Kuchuk, SM Bierma-Zeinstra, AC Marijnissen, FP Lafeber, ...
Annals of the Rheumatic Diseases 74 (Suppl 2), 370-371, 2015
Mandates: Netherlands Organisation for Health Research and Development
Available somewhere: 111
Review
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 …
FM Blows, KE Driver, MK Schmidt, A Broeks, FE Van Leeuwen, ...
PLoS medicine 7 (5), e1000279, 2010
Mandates: US National Institutes of Health, Cancer Research UK
Review
Reversible and adaptive resistance to BRAF (V600E) inhibition in melanoma
C Sun, L Wang, S Huang, GJJE Heynen, A Prahallad, C Robert, ...
Nature 508 (7494), 118-122, 2014
Mandates: Canadian Institutes of Health Research, European Commission, Dutch Cancer …
Review
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer
RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ...
Nature genetics 49 (12), 1767-1778, 2017
Mandates: US National Institutes of Health, National Health and Medical Research …
Review
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk …
LE Elshof, K Tryfonidis, L Slaets, AE van Leeuwen-Stok, VP Skinner, N Dif, ...
European journal of cancer 51 (12), 1497-1510, 2015
Mandates: Dutch Cancer Society
Review
Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
S Jones, M Li, DW Parsons, X Zhang, J Wesseling, P Kristel, MK Schmidt, ...
Human mutation 33 (1), 100-103, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Personalized early detection and prevention of breast cancer: ENVISION consensus statement
N Pashayan, AC Antoniou, U Ivanus, LJ Esserman, DF Easton, D French, ...
Nature reviews Clinical oncology 17 (11), 687-705, 2020
Mandates: Cancer Research UK, National Institute for Health Research, UK, European …
Review
Ductal carcinoma in situ: to treat or not to treat, that is the question
M van Seijen, EH Lips, AM Thompson, S Nik-Zainal, A Futreal, ES Hwang, ...
British journal of cancer 121 (4), 285-292, 2019
Mandates: Cancer Research UK, Dutch Cancer Society
Review
Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration
V Bossuyt, E Provenzano, WF Symmans, JC Boughey, C Coles, ...
Annals of oncology 26 (7), 1280-1291, 2015
Mandates: US National Institutes of Health, Cancer Research UK
Review
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients
C Yau, M Osdoit, M van der Noordaa, S Shad, J Wei, D de Croze, ...
The Lancet Oncology 23 (1), 149-160, 2022
Mandates: US National Institutes of Health, Cancer Research UK, National Institute for …
Review
Mechanisms of therapy resistance in patient-derived xenograft models of BRCA1-deficient breast cancer
P Ter Brugge, P Kristel, E Van Der Burg, U Boon, M De Maaker, E Lips, ...
Journal of the National Cancer Institute 108 (11), djw148, 2016
Mandates: Netherlands Organisation for Scientific Research, European Commission …
Review
Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
S Rontogianni, E Synadaki, B Li, MC Liefaard, EH Lips, J Wesseling, ...
Communications biology 2 (1), 325, 2019
Mandates: Netherlands Organisation for Scientific Research
Publication and funding information is determined automatically by a computer program